Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00051974. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Open-Label, Phase 2 Study of VELCADE Alone or VELCADE Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate how tumors in patients with non-small cell lung cancer respond to treatment with VELCADE alone versus VELCADE given with docetaxel and also to see what effects (good and bad) it has on you and your cancer.
Study identification
- NCT ID
- NCT00051974
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 155 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2002
- Primary completion
- Aug 31, 2004
- Completion
- Not listed
- Last update posted
- Feb 10, 2008
Started 2002
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| U of Alambama at Birmingham Comprehensive Cancer Center | Birmingham | Alabama | 35294 | — |
| Cedars-Sinai Comprehensive Cancer Center | Los Angeles | California | 90048 | — |
| UCLA Medical Center Thoracic Malignancy | Los Angeles | California | 90095 | — |
| University of Colorado Health Sciences Center | Aurora | Colorado | 80010 | — |
| Yale University School Of Medicine | New Haven | Connecticut | 06520 | — |
| Univeristy of Florida Shands Cancer Center | Gainesville | Florida | 32610 | — |
| Sylvester Comprehensive Cancer Center | Miami | Florida | 33136 | — |
| Winship Cancer Institute | Atlanta | Georgia | 30322 | — |
| Atlanta VAMC | Decatur | Georgia | 30033 | — |
| Mass. General Hospital Hem/Onc. Associates | Boston | Massachusetts | 02114 | — |
| DBA Kansas City Cancer Centers | Kansas City | Missouri | 64154 | — |
| St. Louis University Health Sciences Center | St Louis | Missouri | 63110 | — |
| Washington University, Barnard Cancer Center | St Louis | Missouri | 63110 | — |
| Carolinas Hematology-Oncology Associates | Charlotte | North Carolina | 28203 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Kimmel Cancer Center at Jefferson | Philadelphia | Pennsylvania | 19107 | — |
| Vanderbilt University-Clinical Trials Center | Nashville | Tennessee | 37232 | — |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Hunstman Cancer Institute-University of Utah | Salt Lake City | Utah | 84112 | — |
| University of Wisconsin Comprehensive Cancer Center | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00051974, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 10, 2008 · Synced Sep 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00051974 live on ClinicalTrials.gov.